Abstract
Hepatitis E — formerly called ‘enterically transmitted non-A non-B hepatitis’ — is transmitted by the faecal-oral route. The Hepatitis E Virus (HEV) is a positive-sense single-stranded RNA virus and has great similarities to the caliciviruses. Virus replication appears to be limited to the hepatocyte. The disease is especially endemic and/or epidemic on the Indian sub-continent. Epidemics are mostly waterborne infections. Also in other ‘developing regions’ outbreaks of HEV infection are observed. In industrialised countries this disease only plays a minor role in hepatitis infections. HEV causes epidemics, endemics and sporadic cases of acute hepatitis. The incubation period for hepatitis E varies from 2–9 weeks. The course of disease is usually mild and self-limiting and resolves within a 2 weeks period. Fulminant cases of infection are rare. HEV infection does not induce chronic courses of hepatitis or liver disease. In clinically apparent cases of infection jaundice, pruritus, clay-coloured faeces and generalised lymphadenopathia may be observed. Fatal infections of fulminant hepatitis E are rare. Pregnant women appear to be exceptionally susceptible to severe disease forms, with an excessive mortality of infected mothers of about 20% in this group. HEV infections appearingly induce mostly life-long immunity to re-infection. To date there is no therapy against HEV infection available. The attempts in generating a vaccine against HEV infections are promising. Improving the socioeconomic situation — including hygienic conditions — is the most effective measure of disease prevention.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Khudyakov Y, Fields HA (2002) HEV-Like-Viruses. In: CA Tidona, G Darai (eds) In: The Springer Index of Viruses. Springer Publ, Berlin, 1251–1254
Gorbach SL, Bartlett JG, Blacklow NR (eds) (1998) Infectious Diseases. WB. Saunders, Philadelphia
Reyes GR, Huang CC, Tam AW, Purdy MA (1993) Molecular organization and replication of hepatitis E virus (HEV). Arch Virol 7: 15–25
Chauhan A, Diliwari JB, Kaur U, Ganguly NK, Bushnurmath S, Chawla YK (1994) Atypical strains of hepatitis E virus (HEV) from north India. J Med Virol 44: 22–29
Krawczynski K (1993) Hepatitis E. Hepatology 17: 932–941
Huang R, Li D, Wei S, Li Q, Yuan X, Geng L, Li X, Liu M (1999) Cell culture of sporadic hepatitis E virus in China. Clin Diagn Lab Immunol 6: 729–733
Viswanathan R, Sidhu AS (1957) Infectious hepatitis: clinical findings. Ind J Med Res 45: 49–58
Wong DC, Purcell RH, Sreenivasan MA, Prasad SR, Pavri KM (1980) Epidemic and endemic hepatitis in India: evidence for a non-A, non-B hepatitis virus aetiology. Lancet 2(8200): 876–879
Balayan MS, Andjaparidze AG, Savinskaya SS, Ketiladze ES, Braginsky DM, Savinov AP, Poleschuk VF (1983) Evidence for a virus in non-A, non-B hepatitis transmitted via the fecal-oral route. Intervirology 20: 23–31
Goldsmith R, Yarbough PO, Reyers GR, Fry KE, Gabor KA, Kamel M, Zakaria S, Amer S, Gaffar Y (1992) Enzyme-linked immunosorbent assay for diagnosis of acute sporadic hepatitis E in Egyptian children. Lancet 339: 328–331
Koff RS (1998) Hepatitis E. In: SL Gorbach, JG Bartlett, NR Blacklow (eds) In: Infectious Diseases. W.B. Saunders, Philadelphia, 871–873
Arankalle VA, Chadha MS, Tsarev SA, Emerson SU, Risbud AR, Banerjee K, Purcell RH (1994) Seroepidemiology of water-borne hepatitis in India and evidence for a third enterically-transmitted hepatitis agent. Proc Natl Acad Sci USA 91: 3428–3432
Velazquez O, Stetler HC, Avila C, Ornelas G, Alvarez C, Hadler SC, Bradley DW, Sepúlveda J (1990) Epidemic transmission of enterically transmitted non-A, non-B hepatitis in Mexico, 1986–1987 JAMA 263: 3281–3285
Pujol FH, Favorov MO, Marcano T, Esté JA, Magris M, Liprandi F, Khudyakov YE, Khudyakova NS, Fields HA (1994) Prevalence of antibodies against hepatitis E virus among urban and rural populations in Venezuela. J Med Virol 42: 234–236
Nanda SK, Ansari IH, Acharya SK, Jameel S, Panda SK (1995) Protracted viremia during acute sporadic hepatitis E virus infection. Gastroenterology 108: 225–230
Jilani N, Das BC, Husain SA, Baweja UK, Chattopadhya D, Gupta RK, Sardana S, Kar P (2007) Hepatitis E virus infection and fulminant hepatic failure during pregnancy. J Gastroenterol Hepatol 5: 676–682
Boccia D, Guthmann JP, Klovstad H, Hamid N, Tatay M, Ciglenecki I, Nizou JY, Nicand E, Guerin PJ (2006) High mortality associated with an outbreak of hepatitis E among displaced persons in Darfur, Sudan. Clin Infect Dis 42: 1679–1684
Bryan JP, Tsarev SA, Iqbal M, Ticehurst J, Emerson S, Ahmed A, Duncan J, Rafiqui AR, Malik IA, Purcell RH (1994) Epidemic hepatitis E in Pakistan: patterns of serologic response and evidence that antibody to hepatitis E virus protects against disease. J Infect Dis 170: 517–521
Khuroo MS, Rustgi VK, Dawson GJ, Mushawar IK, Yattoo GN, Kamili S, Khan BA (1994) Spectrum of hepatitis E virus infection in India. J Med Virol 42: 281–286
Lin CX, Wu T, Wu XL, Xie MH, Cheng T, Li SW, Zhang J, Xia NS (2007) Priming with an HEV Th epitope can improve the humoral immunogenicity of its native protein (Chinese). Sheng Wu Gong Cheng Xue Bao 23: 310–314
Tsarev SA, Tsareva TS, Emerson SU, Govindarajan S, Shapiro M, Gerin JL, Purcell RH (1994) Successful passive and active immunization of Cynomolgus monkeys against hepatitis E. Proc Natl Acad Sci USA 91: 10198–10202
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2008 Birkhäuser Verlag Basel/Switzerland
About this chapter
Cite this chapter
Schmidt, A., Wolff, M.H. (2008). Hepatitis E infection. In: Weber, O., Protzer, U. (eds) Comparative Hepatitis. Birkhäuser Advances in Infectious Diseases. Birkhäuser Basel. https://doi.org/10.1007/978-3-7643-8558-3_7
Download citation
DOI: https://doi.org/10.1007/978-3-7643-8558-3_7
Publisher Name: Birkhäuser Basel
Print ISBN: 978-3-7643-8557-6
Online ISBN: 978-3-7643-8558-3
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)